Zimmer Biomet officer granted 1,857 RSUs

Noor Jehanzeb reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Noor Jehanzeb reported acquisition or exercise transactions in this Form 4 filing.

ZIMMER BIOMET HOLDINGS, INC. officer Noor Jehanzeb received a grant of 1,857 Restricted Stock Units, each representing a right to one share of common stock. These RSUs vest over three years in equal one-third installments starting on June 1, 2027. After this award, Jehanzeb holds 1,857 RSUs directly.

Insider Trade Summary

Grant/Award: 1,857 shares

Grant/Award 1 txn

Insider Noor Jehanzeb

Role See remarks below.

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	1,857	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 1,857 contracts (Direct)

Footnotes (2)

1. F1. Each RSU represents a contingent right to receive one share of Company common stock.
2. F2. Vests annually over three years in increments of one-third each year, commencing June 1, 2027.

Key Figures

RSUs granted: 1,857 units RSUs after transaction: 1,857 units RSU price: $0.0000 per unit +3 more

6 metrics

RSUs granted 1,857 units Restricted Stock Units granted on June 1, 2026

RSUs after transaction 1,857 units Total Restricted Stock Units held directly after grant

RSU price $0.0000 per unit Reported transaction price per Restricted Stock Unit

Underlying common shares 1,857 shares Common stock underlying granted Restricted Stock Units

Vesting start June 1, 2027 First vesting date for the RSU award

Vesting pattern One-third annually over 3 years RSU vesting schedule commencing June 1, 2027

Key Terms

Restricted Stock Units, contingent right, vests annually, derivative

4 terms

Restricted Stock Units financial

"Each RSU represents a contingent right to receive one share of Company common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each RSU represents a contingent right to receive one share of Company common stock."

vests annually financial

"Vests annually over three years in increments of one-third each year, commencing June 1, 2027."

derivative financial

"The transaction is classified as a derivative transaction involving Restricted Stock Units."

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ZBH officer Noor Jehanzeb report on this Form 4?

Noor Jehanzeb reported receiving 1,857 Restricted Stock Units as a compensation grant. Each RSU represents a right to one share of Zimmer Biomet common stock, providing equity-based incentive aligned with shareholder interests over a multi-year vesting schedule.

How many ZBH Restricted Stock Units were granted to Noor Jehanzeb?

Jehanzeb received 1,857 Restricted Stock Units in this transaction. These RSUs are a form of stock-based compensation and, if they vest, will convert into the same number of Zimmer Biomet common shares over the defined vesting period.

What is the vesting schedule for Noor Jehanzeb’s ZBH RSU award?

The 1,857 RSUs vest annually over three years in equal one-third increments. Vesting begins on June 1, 2027, meaning portions of the award become deliverable each year, subject to continued service or other conditions in the underlying award agreement.

Does the ZBH RSU grant to Noor Jehanzeb involve any purchase price?

The RSU grant shows a per-unit price of $0.0000, reflecting that it is an equity award, not a market purchase. Shares underlying RSUs are typically delivered without additional payment if vesting conditions are satisfied under the company’s compensation plan.

How many ZBH RSUs does Noor Jehanzeb hold after this reported transaction?

Following this grant, Jehanzeb’s direct holdings total 1,857 Restricted Stock Units. These units, if fully vested according to schedule, would convert into 1,857 shares of Zimmer Biomet common stock, increasing the officer’s equity exposure to the company.

What type of security was involved in Noor Jehanzeb’s ZBH Form 4 filing?

The filing involves Restricted Stock Units, a derivative security tied to Zimmer Biomet common stock. Each RSU represents a contingent right to receive one common share, subject to the three-year vesting schedule that starts on June 1, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Noor Jehanzeb

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks below.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/01/2026		A		1,857		(2)	(2)	Common Stock	1,857	$0	1,857	D

Explanation of Responses:

1. Each RSU represents a contingent right to receive one share of Company common stock.

2. Vests annually over three years in increments of one-third each year, commencing June 1, 2027.

Remarks:

Senior Vice President, Chief Strategy, Innovation & Business Development Officer

	/s/ Matthew R. St. Louis, Attorney-in-fact for Jehanzeb Noor (power of attorney previously filed)	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)